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Abstract
When plasmonic nanoparticles (NPs) are internalized by cells and agglomerate within intracellular vesicles, their
optical spectra can shift and broaden as a result of plasmonic coupling of NPs in close proximity to one another.
For such optical changes to be accounted for in the design of plasmonic NPs for light-based biomedical
applications, quantitative design relationships between designable factors and spectral shifts need to be
established. Here we begin building such a framework by investigating how functionalization of gold NPs (AuNPs)
with biocompatible poly(ethylene) glycol (PEG), and the serum conditions in which the NPs are introduced to cells
impact the optical changes exhibited by NPs in a cellular context. Utilizing darkfield hyperspectral imaging, we find
that PEGylation decreases the spectral shifting and spectral broadening experienced by 100 nm AuNPs following
uptake by Sk-Br-3 cells, but up to a 33 ± 12 nm shift in the spectral peak wavelength can still occur. The serum
protein-containing biological medium also modulates the spectral changes experienced by cell-exposed NPs
through the formation of a protein corona on the surface of NPs that mediates NP interactions with cells: PEGylated
AuNPs exposed to cells in serum-free conditions experience greater spectral shifts than in serum-containing
environments. Moreover, increased concentrations of serum (10, 25, or 50 %) result in the formation of smaller
intracellular NP clusters and correspondingly reduced spectral shifts after 5 and 10 h NP-cell exposure. However,
after 24 h, NP cluster size and spectral shifts are comparable and become independent of serum concentration. By
elucidating the impact of PEGylation and serum concentration on the spectral changes experienced by plasmonic
NPs in cells, this study provides a foundation for the optical engineering of plasmonic NPs for use in biomedical
environments.
Keywords: Nano-bio interactions, Plasmonics, Hyperspectral imaging, Gold nanoparticles, Cells, Spectral shifting,
Nanomedicine, Poly(ethylene glycol), Serum, Protein corona
Background
Plasmonic metal nanoparticles (NPs) are employed in a
variety of biomedical applications, ranging from in vitro
quantitative study of biological processes to in vitro and
in vivo photonic gene circuits and photothermal therapy
[1–7]. Optical excitation of metal NPs at particular
wavelengths generates a resonant collective oscillation of
the NPs’ conduction electrons, termed “plasmon reson-
ance,” which manifests as strong absorption or scattering
of light. The wavelength of light at which metal NPs
exhibit maximal plasmon resonance is highly sensitive to
the NPs’ geometry, compositional material, and local
environment [8]. This relationship enables metal NPs to
be engineered for optical absorption or scattering at
desired wavelengths for biomedical applications by
fabricating NPs with a geometry and material compos-
ition that provide the desired optical response. Metal
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NPs designed in this fashion have been developed for
use as scattering contrast markers [1, 2], optical heat
transducers [7, 9], and multiplexed light-activated gene-
delivery agents [3, 10]. However, it has been shown that
the cellular uptake and agglomeration of plasmonic
nanoparticles in biological environments can result in
coupling of optical resonances, leading to a shift in the
optical spectra of metal nanoparticles [11–13].
Recent advancements in darkfield imaging and process-
ing have enabled spectra of plasmonic nanoparticles in
cells to be captured more efficiently [14–17], therefore
making it possible to quantify the extent of these spectral
shifts. We recently developed a darkfield hyperspectral
(HS) imaging and analysis approach to systematically
quantify the magnitude of these spectral shifts, the associ-
ated spectral broadening, and the variability of the spectral
shifts among cells in a cell population using 100-nm bare
gold NPs (AuNPs) as a model NP [13]. These results
provided quantitative metrics for the first time for asses-
sing the significance of the spectral shifts that occur in a
cellular environment. In order for NPs to be more
precisely designed to account for such cell-associated
spectral changes in biomedical applications (preventing
unintended optical effects and achieving more precise,
predicted optical response), there is a need for further
understanding of how NP design parameters or environ-
mental factors can influence the spectral changes that are
realized in a cellular environment. For example, it is
unknown how NP size, surface chemistry, or cell type will
impact the magnitude of spectral change or broadening of
the NP spectra in a cellular environment. To build a
framework for understanding how much designable
parameters will influence the resulting spectral changes—-
which can aid in accounting for the changes differently
based on the parameters used in an application or to aid
in choosing the proper parameters during NP design to
elicit or avoid the spectral shift—here we study the effect
of (1) coating NPs with poly(ethylene glycol) (PEG) and
(2) serum concentration in the cellular environment.
PEG is one of the most popular coatings for NPs to be
used in in vivo applications because its hydrophilic and
steric nature minimizes protein adsorption and reduces
detection by the reticulo-endothelial clearance system
(RES), prolonging blood circulation for improved cellular
target delivery [18]. In certain in vitro cellular diagnostic
or gene-delivery applications, PEG-free NPs are used [3, 5,
19] while in other applications, especially those that are in
vivo, NPs are often functionalized with PEG (“PEGylated”)
[20, 21]. Walkey and colleagues demonstrated that AuNPs
not grafted with PEG (“bare AuNPs”) or grafted with differ-
ent densities of PEG exhibited major differences in the cel-
lular uptake and intracellular agglomeration state [22].
Transmission electron microscopy (TEM) imaging showed
that increasing the PEG density decreased intracellular
agglomeration of NPs and reduced the number of NPs per
vesicle following incubation with J774A.1 macrophages
[22]. These previous results suggest a possibility that the ex-
tent of spectral shifting for AuNPs following cellular inter-
action could depend on whether they are PEGylated since
the optical properties of plasmonic NPs are highly sensitive
to their local dielectric environment and proximity to other
plasmonic NPs [8, 23, 24]. Furthermore, it is unknown if
the added PEG layer on PEGylated AuNPs provides a suffi-
cient separation distance between NPs when PEGylated
AuNPs are clustered within intracellular vesicles, which is
capable of decreasing plasmonic coupling-associated spec-
tral shifts. Because NPs in many applications are PEGylated,
it is therefore important to understand how this factor af-
fects the extent of the shift in the NP spectra that occurs.
In this paper, we seek to quantitatively assess the shifts that
occur when a NP is PEGylated compared with when it is
bare to allow for finer design of the NP optical response for
a given application.
In addition to the properties of the NP, the role of the
biological environment in influencing the extent of these
shifts also needs to be considered. Plasmonic NPs are
being utilized in applications spanning from serum-free to
serum-containing conditions of various serum concentra-
tions [5, 25–29]. Given the importance of the NP’s protein
corona in mediating interactions between NPs and cells
(e.g., cellular uptake and subsequent intracellular trans-
port) [30–33], we hypothesized that the presence and
absence of serum proteins during NP-cell interaction may
importantly modulate the intracellular agglomeration and
spectral shift accompanied by nanoparticles. Lesniak and
Dawson previously showed that silica NPs incubated with
A549 cells in serum-free media had higher uptake and
distinct intracellular localization compared with when
incubated with cells in 10 % serum-containing culture
media due to different mechanisms of interaction with
cells [34]. Zhu and Rotello also showed that increased
serum concentration (from 0 to 10 to 50 % serum) signifi-
cantly decreased uptake of 2-nm AuNPs in HeLa cells
[35]. Dawson et al. also recently showed that NP-cell
interactions differ remarkably in 10 % (in vitro) and 100 %
(in vivo mimicking) serum concentration conditions [29].
These previous studies led us to hypothesize that increased
serum concentrations and a move from in vitro to in vivo
serum levels may lead to smaller NP agglomerates within
cells and smaller shifts in spectra. Such differences could
have implications in the relative importance of considering
cellular uptake-associated spectral changes of NPs in in
vitro applications compared with in in vivo applications.
Consequently, we study the effect of serum concentration
on shifts of the spectra of PEGylated AuNPs following
cellular uptake, aiming to determine to what extent the NP
spectra may additionally change in conditions when the
serum concentration may be different.
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By applying the HS imaging and analysis approach we
previously established, in this paper, we therefore quantify
the spectral changes experienced in cellular environments
by PEGylated AuNPs as compared with bare AuNPs and
study how spectra are further impacted by serum
concentration (0, 10, 25, or 50 % human serum). We
explain the impact of these NP design and environmental
factors on the spectral changes exhibited by considering
the differences in NP protein corona and intracellular
agglomeration. This study demonstrates how HS imaging
can be utilized to construct a design framework to enable
more precise design of plasmonic NPs for light-based
biomedical applications.
Methods
Functionalization of AuNPs with PEG
Citrate-stabilized spherical AuNPs (100 nm, Ted Pella)
were sonicated to ensure particles were well-separated
before functionalization. To functionalize AuNPs with
PEG, AuNPs at a concentration of 5.6 × 109 NPs/mL were
incubated overnight with 11.6 μM (end concentration) of
methoxy-terminated thiolated PEG (mPEG-SH, MW=
5000 Da, NanoCS). To ensure optimal surface coverage of
PEG, the solution was progressively raised to 10-mM
sodium phosphate, 0.1 % v/v Tween 20, and 0.1 M NaCl
and incubated overnight. Excess PEG molecules were then
removed by three washing steps of centrifugation at 3000g
for 30 min followed by re-suspension in milliQ water.
PEGylated AuNPs were stored at 4 °C until use.
Introducing PEGylated AuNPs to Cells
Sk-Br-3 breast adenocarcinoma cells (American Type
Culture Collection) were cultured in McCoy’s 5A growth
media supplemented with 10 % v/v human off-the-clot
type AB serum (Valley Biomedical) and 1 % penicillin-
streptomycin and maintained at 37 °C in a 5 % CO2 incu-
bator. For incubation time and exposure dose experi-
ments, Sk-Br-3 cells were plated in LabTek II CC2 four-
well chamber slides at a density of 100,000 cells/mL and
grown to 70 % confluence. After 24 h, culture media was
removed and cells were incubated with PEGylated AuNPs
in complete phenol-red free media (CPRFM) containing
10 % HuS for 2, 5, 10, or 24 h in an incubator at 37 °C and
5 % CO2 as described previously in detail [13]. For human
serum (HuS) concentration experiments, Sk-Br-3 cells
were cultured in McCoy’s 5A media supplemented with
1 % penicillin-streptomycin and either 10, 25, or 50 % v/v
human off-the-clot type AB serum (Valley Biomedical).
Sk-Br-3 cells cultured in media containing 25 or 50 % v/v
HuS were weaned progressively from media containing
10 % v/v HuS through the course of multiple passages.
Cells were then plated into LabTek II CC2 four-well
chamber slides at a density of 100,000 cells/mL in media
containing their respective concentration of serum. After
24 h, culture media was removed from wells. Wells with
cells cultured in media with 10 % v/v HuS were then
incubated with 24 μg/mL of PEGylated AuNPs either in
PRFM (0 % HuS) or in CPRFM containing 10 % HuS.
Wells with cells cultured in media with 25 % or 50 % v/v
HuS were incubated with 24 μg/mL PEGylated AuNPs in
CPRFM containing their respective HuS concentrations.
Cells were incubated with PEGylated AuNPs in these
serum concentration conditions (0, 10, 25, or 50 % HuS)
for 5, 10, or 24 h before spectral measurements were
performed.
Measuring Optical Spectra for PEGylated AuNPs
Introduced to Cells
Following incubation with PEGylated AuNPs, cells were
rinsed three times with 1X Dulbecco’s phosphate buffered
saline without magnesium and calcium (PBS, Invitrogen) to
remove extracellularly bound NPs. Cells were fixed using
4 % formaldehyde (15 min, BD Biosciences) and rinsed again
two times with PBS. Chamber slides with cells and internal-
ized PEGylated AuNPs were wetted with PBS, covered with
a coverslip, and sealed with nailpolish to prevent drying.
Cells were imaged at 40× magnification (Plan Fluorite,
NA = 0.75, Olympus) using an Olympus BX-41 upright
microscope with a CytoViva high-resolution illuminator
and a quartz halogen lamp with aluminum reflector (400–
1000 nm). The CytoViva Hyperspectral Imaging System
was used to collect spectral data across the sample through
automated movement of the sample across a transmission
diffraction grating spectrograph (Specim) using a X-Y
motorized stage (Prior). In order to measure spectra pri-
marily originating from NPs within the cells, darkfield HS
images were taken 5 μm above the slide plane (controlled
by a Prior motorized z focus drive with 0.002 μm minimum
step size; see Additional file 1 of [13] for more details). HS
images, which contain full spectral data at each X-Y pixel
location, were analyzed using ENVI software (ITT Visual
Information Solutions). As we previously reported [13], cell
regions of interest (“cell ROIs”) were defined to measure
spectra representing the cellular-level optical response. Cell
ROIs were defined by tracing around cell boundaries using
the polygon ROI tool (see Additional file 1 of [13] for more
details). To ensure objectivity in analysis, all cells within a
HS image were defined as long as cell boundaries could be
unambiguously identified. Spectral data averaged across the
pixels of each ROI was extracted by the ENVI software.
Spectral data was divided by the normalized lamp spectrum
to calibrate for variations in lamp intensity.
Peak Wavelength Determination
To objectively determine the peak wavelengths of spectra,
the peak analyzer function of OriginPro 9.1 Data Analysis
and Graphing Software (OriginLab) was employed.
Savitzky-Golay smoothing with a window size of 50 was
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performed, followed by peak finding using a local
maximum method with two local points. Spectra that
were dominated by cell scattering (characterized by an
optical spectrum that monotonically decreases in intensity
with longer wavelengths) and had insufficient NP spectral
contributions were excluded from analysis since a peak
wavelength could not be accurately assessed [13]. Spectra
were deemed cell scattering-dominated and not included
in analysis if the normalized intensity at 500 nm was 0.95
or higher [13].
Spectral Broadening Measurement
To calculate the spectral broadness, defined as the width
of the spectrum at 95 % of the maximum intensity, a
custom MATLAB program was utilized which was
discussed in full detail previously [13]. Briefly, spectra
were smoothed using a Savitzky-Golay algorithm and
shifted downward by a constant value equivalent to 95 %
of the spectrum’s maximum intensity. The difference
between the two points of zero crossing was then calcu-
lated, which represented the spectral width at 95 % of
the spectrum’s maximum intensity.
Characterizing Spectral Shift of PEGylated AuNPs in
CPRFM
To measure the shift in NP spectra attributed to protein
corona formation or agglomeration in CPRFM prior to
cellular uptake, extinction spectra were collected using
an Agilent Cary 60 UV-vis spectrophotometer. Spectra
were measured for PEGylated AuNPs in water as well as
in CPRFM (containing phenol-red free McCoy’s 5A
media (HyClone), 1 % penicillin-streptomycin (Sigma-
Aldrich) and either 0, 10, 25, or 50 % HuS (Valley Bio-
medical)) through time. PEGylated 100-nm AuNPs were
centrifuged, redispersed in CPRFM, and incubated at
37 °C and 5 % CO2 in a cell culture incubator. NPs in
water only and CPRFM alone were also kept under same
conditions. All spectra were collected with water as the
baseline.
Cellular TEM for Bare and PEGylated AuNPs
Following incubation with NPs, cells were rinsed three
times with 1× PBS, fixed with 2.5 % formaldehyde/2.5 %
glutaraldehyde in 0.1-M sodium cacodylate buffer
(Electron Microscopy Sciences) at room temperature,
and kept at 4 °C overnight. After fixation, the samples
were washed in 0.1-M cacodylate buffer and treated with
0.1 % Millipore-filtered buffered tannic acid, post-fixed
with 1 % buffered osmium tetroxide for 30 min, and
stained en bloc with 1 % Millipore-filtered uranyl
acetate. The samples were washed several times in water,
then dehydrated in increasing concentrations of ethanol,
infiltrated, and embedded in Spurr’s low viscosity
medium. The samples were polymerized in a 60 °C oven
for 2 days. Ultrathin sections were cut in a Leica
Ultracut microtome, stained with uranyl acetate and lead
citrate in a Leica EM Stainer, and examined in a JEM
1010 transmission electron microscope (JEOL, USA,
Inc.) at an accelerating voltage of 80 kV. Digital images
were obtained using an AMT Imaging System
(Advanced Microscopy Techniques Corp).
Cellular TEM for PEGylated AuNPs Introduced in Different
HuS Conditions
Following incubation with NPs, cells were rinsed three
times with 1× PBS and fixed with 2.5 % formaldehyde/
2.5 % glutaraldehyde in 0.1-M sodium cacodylate buffer at
4 °C. After fixation, the samples were washed in 0.1-M
cacodylate buffer and post-fixed with buffered osmium
tetroxide for 30 min. The samples were washed several
times in double-distilled water, then dehydrated in increas-
ing concentrations of ethanol, infiltrated, and embedded in
Spurr’s low viscosity medium. The samples were polymer-
ized in a 60 °C oven overnight. Ultrathin sections were cut
on an RMC MT6000XL microtome and examined
unstained on a JEM 1230 transmission electron microscope
(JEOL, USA, Inc.) at an accelerating voltage of 80 kV.
Digital images were obtained using a US1000 high-
resolution digital camera (Gatan, Inc., Pleasanton, CA).
Statistical Analysis
In comparisons of spectral peak wavelengths among dif-
ferent serum concentration conditions, statistical signifi-
cance was evaluated by performing one-factor analysis
of variance (ANOVA) followed by a post hoc Tukey’s
HSD test for multiple comparisons. P values less than
0.01 were considered statistically significant. In compari-
sons made between spectral peak wavelengths (and spec-
tral width) of bare and PEGylated AuNPs following
uptake by cells, a two-tailed Student’s t test was
performed. P values less than 0.01 were considered
statistically significant.
Results and Discussion
PEGylation of Nanoparticles Decreases Spectral Shift
Exhibited in Cellular Environment
To study the effect of PEGylation on how the optical
properties of nanoparticles change upon cellular uptake,
we incubated breast cancer (Sk-Br-3) cells with 100-nm
AuNPs functionalized with 5 kDa MW methoxy-
terminated poly(ethylene glycol) (mPEG-SH). Cells were
incubated with PEGylated AuNPs for 2, 5, 10, or 24 h at
12, 24, 48, or 96 μg/mL exposure doses. Following NP
exposure, cells were imaged using darkfield hyperspectral
(HS) imaging, in which complete optical scattering spectra
can be obtained at each pixel location within the images.
We employed our previously reported analysis approach
to follow changes in the optical spectra following NP
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interaction and uptake by the Sk-Br-3 cells [13]. As seen
in the representative HS images and corresponding spec-
tra in Fig. 1 for cells exposed either to bare or PEGylated
AuNPs for 24 h at a dose of 24 μg/mL, PEGylated NPs
and bare NPs interacted with cells in distinctly different
ways, with bare NPs forming large clusters in cells. The
corresponding spectra (only a subset is shown for clarity)
measured from cells exposed to bare and PEGylated NPs
differ in both peak wavelength and broadness.
Quantitative analysis resulting from extracting the spectra
from more than 35 individual cells in each condition deter-
mined that NPs exhibit less spectral shift following cellular
uptake when they are functionalized with PEG as compared
with when they are bare (Fig. 2a). While spectra for bare
AuNPs shifted by as much as 79 ± 24 nm between 2 and
24 h of incubation, spectra for PEGylated AuNPs shifted a
maximum of 33 ± 12 nm (Fig. 2a). The spectral shift mea-
sured for PEGylated AuNPs was greater than can be attrib-
uted to changes in local surrounding dielectric constant
associated with the formation of a protein corona on the
PEGylated AuNP surface in cell culture media prior to cell
uptake (See Additional file 1: Figure S1) or the contribution
of the cellular refractive index of 1.33~1.38 [13, 36, 37]. As
seen in Fig. 2a, 12 to 96 μg/mL exposure doses of bare
AuNPs resulted in spectra with peak wavelengths ranging
from 623 ± 25 to 645 ± 23 nm after 24-h incubation with
cells, while the same exposure doses of PEGylated AuNPs
only resulted in spectra with peak wavelengths ranging
from 569 ± 4 nm to 615 ± 12 nm.
The smaller spectral shift experienced by PEG-
coated AuNPs compared with bare AuNPs may be at-
tributed to the differences in cellular interaction and
intracellular trafficking of the two types of AuNPs.
PEGylated AuNPs interface differently with cells than
do bare AuNPs due to the sterically hindering poly-
mer chains presented on their surface and resulting
different surface charge [38, 39]. The PEG layer has
been found not only to reduce serum protein adsorp-
tion but also to impact the composition of the NP’s
protein corona [22], which influences where NPs are
transported within cells. Compared with bare AuNPs,
PEGylated AuNPs have been shown to experience de-
creased cellular uptake and distinct patterns of intra-
cellular distribution and agglomeration [38, 39].
Fig. 1 Representative hyperspectral (HS) images and optical spectra showed differences in cellular interaction for bare and PEGylated AuNPs, which
corresponded to spectra that differed in peak wavelength and broadness. Shown are representative HS images of Sk-Br-3 cells after exposure to
24 μg/mL of bare or PEGylated AuNPs for 24 h and representative optical spectra extracted from regions of interest (ROIs) defined around individual
cells (“cell ROIs”) in the measured HS images (only ten ROIs and only one of the analyzed HS images are shown here for clarity). Scale bar denotes 20
μm. The representative HS image and optical spectra for bare AuNPs are reproduced from ref [13] with permission as a reference for comparison with
the representative HS image and optical spectra for PEGylated AuNPs
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Indeed, cellular TEM imaging showed that the decreased
shifts for PEGylated AuNPs in cells correlated with the
formation of smaller intracellular NP clusters (NPCs) as
compared with bare AuNPs under the same exposure dose
and time conditions (Fig. 3). For example, following expos-
ure of cells to 24 μg/mL of bare or PEGylated AuNPs for
24 h, vesicles showed 1–5 NPs in each cell slice for bare
NPs as compared with 1–3 NPs for PEGylated AuNPs
(Note: TEM images are taken from cell slices, and thus, the
actual number of NPs per vesicle is larger due to the 3D
nature of vesicles within cells. The number of NPs within
vesicles from cell slices is provided for relative comparison.
Cell slices were consistently taken approximately 1.5 μm
into the cell). Likewise, at the 96 μg/mL exposure dose,
larger NP clusters (NPCs) were observed in cells exposed
to bare AuNPs than in cells exposed to PEGylated AuNPs
(~8–12 NPs per NPC vs. 2–6 NPs per NPC in TEM cell
slices; see Fig. 3, Additional file 1: Figure S2, and Additional
file 1 of [13]).
Our observations are consistent with previous studies in
human alveolar epithelial cells and mouse macrophage
cells which reported that PEGylated NPs formed smaller
Fig. 2 PEGylated AuNPs experienced less spectral shifting and broadening in cells than bare AuNPs, as determined by hyperspectral imaging
analysis. a Peak wavelengths of cell ROI spectra following exposure of bare and PEGylated AuNPs to Sk-Br-3 cells. Dotted lines denote the peak
wavelength of UV-vis spectra for bare and PEGylated AuNPs in water in the absence of cells. b Spectral width at 95 % maximum intensity after
24 h for bare and PEGylated AuNPs. Error bars indicate SEM. Spectral peak wavelengths were measured from more than 35 cell ROIs for each
condition. * indicates statistically significant difference (p < 0.01) based on two-tailed Student’s t test. Data for bare AuNPs are re-plotted here
from ref [13] with permission as a reference for comparison with data for PEGylated AuNPs
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intracellular agglomerates than did bare AuNPs [22, 39]
and experienced decreased cellular uptake [40]. However,
in comparison to a previous study that observed that
PEGylated NPs were better dispersed and spaced out from
one another within vesicles of macrophage cells [22], we
did not observe a significant difference in distance among
particles for the PEGylated NPs compared with for the
bare AuNPs within endosomes in the Sk-Br-3 cells used in
our study (Fig. 3). The decreased spectral shift for PEGy-
lated AuNPs that we observed appears to be mainly due
to the smaller size of AuNP clusters that form when
PEGylated AuNPs are uptaken by cells rather than
increased inter-particle distance (and thus a decreased
coupling of nanoparticle plasmon resonances [23])
provided by the PEG layer.
PEGylated AuNPs Experience Less Spectral Broadening
Following Cellular Uptake than Bare AuNPs
The broadness of spectra determines the range of
wavelengths at which a certain intensity of optical response
(absorption or scattering of light) will be achieved.
Biomedical applications that depend on multiplexing of
NPs resonant at different wavelengths must utilize NPs
with narrow spectral widths in order to prevent uninten-
tional excitation of other NP populations when illuminating
with a particular wavelength [3, 13, 41]. Therefore, we com-
pared the broadening of spectra after the introduction of
bare and PEGylated AuNPs to cells. Since the spectra were
asymmetric, with the left side of the peak often not drop-
ping below 50 % of the maximum intensity, broadness
could not be defined as the full width half maximum
(“FWHM”) [13, 42]. We defined broadness by measuring
the spectral width at 95 % of the maximum intensity (“spec-
tral width”) [13]. As seen in Fig. 2b, PEGylated AuNP spec-
tra were significantly narrower than bare AuNP spectra
following cellular interaction. Whereas the spectral width
of bare AuNPs ranged from 103.4 ± 20.3 nm to 105.9 ±
11.7 nm for all exposure doses after 24 h of cell incubation,
the spectral width for PEGylated AuNPs ranged from 57.5
± 7.4 nm to 74.9 ± 8.9 nm after 24 h incubation.
The decreased broadening for PEGylated AuNPs is
likely because of the decreased heterogeneity in NPC sizes
within cells. Averaging of the various spectra from intra-
cellular NPCs of different sizes and peak wavelengths will
result in a broader spectrum for cells that contain NPCs
of diverse sizes [13]. TEM images suggested that for
PEGylated AuNPs, most intracellular vesicles contained
only 1 to 3 NPs up to a maximum of 8 NPs per vesicle
(within a cell slice) (Fig. 3, Additional file 1: Figure S2). In
comparison, a greater range of NPC sizes (1 to 29 NPs per
vesicle) was observed for bare AuNPs (Fig. 3, Additional
file 1 of [13]). This difference in the range of NPC sizes
found within cells incubated with PEGylated or bare
AuNPs is again likely to stem from the decreased uptake
and unique cellular uptake/intracellular trafficking routes
taken by PEGylated AuNPs (as shown through inhibition
studies previously) [38, 39].
In summary, these results show that PEGylated AuNPs
experience smaller spectral shifting and decreased
broadening in a cellular environment compared with
bare AuNPs, likely due to lower cellular uptake and for-
mation of smaller intracellular clusters. Such results sug-
gest that PEGylating NPs can be utilized as a method for
mitigating changes to NPs’ spectral profiles; however, we
also find that PEGylation does not completely prevent
spectral shifting and broadening, and that the extent of
spectral shifting and broadening is time- and exposure
dose-dependent (Fig. 2).
Serum Concentration Impacts Shift Magnitude of NP
Spectra in Cells
Since plasmonic NPs are exposed to different biological
environments depending on their application (e.g., low
serum concentration for in vitro applications, but high-
serum concentration for in vivo applications), we further
Fig. 3 Representative cellular TEM images showed differences in
cellular uptake and agglomeration for bare and PEGylated AuNPs.
PEGylated NPs associated less with cells, resulting in fewer NPs per
NP cluster (NPC) within cells. The smaller NPCs formed by PEGylated
AuNPs support the smaller shift and broadening of PEGylated AuNP
spectra in a cellular environment that was measured by HS imaging
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studied the effect of serum concentration on the spectral
changes experienced by plasmonic NPs in cells. We chose
0 and 10 % HuS concentrations since plasmonic NPs are
used under serum-free and serum-containing conditions
in vitro. We chose 25 and 50 % HuS to represent higher
serum conditions closer to those found in vivo. Consistent
with a previous study, we did not test concentrations
higher than 50 % HuS so that we could continue providing
nutrients and buffering agents from the base cell culture
media to the cells [35]. Prior to introduction of NPs, cells
were slowly weaned to the 10, 25, or 50 % serum condi-
tions through the course of multiple passages in order to
ensure that measured effects were not due to cellular
shock from a new environment. Cells cultured under
these serum conditions were exposed to NPs suspended
in media containing the respective serum concentrations
and visualized through HS imaging. Quantitative analysis
of HS data showed that at early times (5 and 10 h), serum
concentration impacted the magnitude of spectral shift ex-
perienced by AuNPs in cells; however, after 24 h, cellular
uptake-associated shifting in the NP spectra was compar-
able among the 10, 25, and 50 % HuS conditions (Fig. 4).
At 5 and 10 h, there were distinct differences in the peak
wavelengths of spectra for NPs introduced to cells cultured
in 0, 10, 25, and 50 % HuS conditions. NPs introduced to
cells in serum-free (0 % HuS) conditions exhibited spectra
with significantly longer peak wavelengths than did NPs
exposed to cells in serum-containing (10, 25, and 50 %
HuS) conditions. Serum concentration has recently been
shown to greatly impact the composition and thickness of
the protein corona formed on the NP surface as well as the
cellular uptake of NPs [29, 31, 35]. For instance, Payne et
al. showed that incubation of NPs with serum proteins
could result in either increased or decreased cellular
binding of cationic or anionic NPs as a result of the protein
corona formed on the NP surface [43]. The protein corona
of anionic NPs contained serum albumin, causing the NPs
to bind to cells primarily through the albumin receptor and
resulting in decreased cell binding as they competed with
free albumin proteins to bind the albumin receptor. In
comparison, the protein corona of cationic NPs contained a
denatured form of serum albumin, which caused NPs to
interact with cells through scavenger receptors and experi-
ence increased uptake [43].
Fig. 4 Serum concentration impacted the magnitude of spectral shift experienced by PEGylated AuNPs in cellular environment. Peak
wavelengths of spectra measured from HS imaging are displayed for Sk-Br-3 cells incubated with PEGylated AuNPs in 0, 10, 25, or 50 %
HuS conditions for 5, 10, or 24 h. Error bars indicate SEM for spectral peak wavelengths measured from at least 50 cell ROIs for each
condition. PEGylated AuNPs exposed to cells in serum-free conditions exhibited spectra with peak wavelengths that were significantly
greater than spectra for NPs exposed to cells in serum-containing conditions (10, 25, or 50 % HuS), suggesting a greater spectral shift.
Comparing spectral shifts exhibited by NPs exposed to cells in different serum-containing conditions (10, 25, and 50 % HuS), shifts were
initially smaller at higher HuS conditions (25 and 50 % HuS) as compared with at the 10 % HuS concentration typically used in in vitro
studies. However, after 24 h of exposure, shifts became comparable and were not significantly different among the serum-containing
conditions. * indicates statistically significant difference (p < 0.01) based on ANOVA followed by Tukey’s post hoc HSD test. Note: No peak
wavelength could be calculated at t = 5 h for NPs exposed to cells at 50 % HuS since there was insufficient NP signal and cell scattering
dominated the spectrum (for more information, see [13]). Error bar for 0 % HuS at t = 5 h is smaller than the blue diamond symbol and
therefore not visible
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Here in our study, our PEGylated AuNPs were slightly
anionic (see Additional file 1: Table S1), and they experi-
enced smaller spectral shifts in serum-containing media
(10, 25, and 50 % HuS) compared with serum-free media
(0 % HuS) (Fig. 4). These results agree with Payne’s
study in that the presence of serum for our anionic
AuNPs likely resulted in the formation of a specific pro-
tein corona that caused the NPs to engage particular cell
receptors and take a distinct route of internalization and
intracellular transport with less cellular uptake. Decreased
cellular uptake of the NPs can result in each intracellular
vesicle containing fewer NPs, leading to a smaller chance
for plasmonic coupling and spectral shift.
At 5 and 10 h of NP exposure, AuNPs also showed
decreased spectral red-shifting as serum concentration
increased from 10 to 25 and 50 % HuS (Fig. 4). Previous
studies have demonstrated that increased serum concentra-
tions can lead to decreased cellular uptake of functionalized
AuNPs or amine-modified polystyrene NPs [29, 35]. There-
fore, decreased cellular uptake of NPs by cells incubated in
higher serum concentrations may be one factor explaining
the minimal change in spectral peak wavelength for NPs
incubated with cells in the high-serum (25 and 50 % HuS)
conditions at 5 and 10 h. In addition to cellular uptake, the
critical factor determining the extent of shift in the NP
spectra is the configuration of NP agglomerates in intracel-
lular vesicles. In Fig. 5, representative TEM images of cells
at t = 10 h show that at the highest serum concentrations
(25 and 50 % HuS), fewer NPs (1-2 NPs) were found within
each intracellular vesicle as compared with for cells exposed
to NPs in 10 % HuS or serum-free (0 % HuS) conditions
(see also Additional file 1: Figure S3). The decreased
number of NPs found within intracellular vesicles for cells
cultured in higher serum concentration conditions is
consistent with the smaller shift in the NP spectra that was
measured (Fig. 4).
Interestingly, after 24 h of incubation of the PEGylated
AuNPs with cells, there was no longer a significant differ-
ence in the spectral peak wavelength among the 10, 25,
and 50 % HuS conditions (Fig. 4). We hypothesize that
this is due to “cellular conditioning” of the extracellular
media through secretion of solutes, proteins, and ions by
cells. Albanese and Chan recently showed that this natural
ongoing secretion of proteins and molecules by cells into
the extracellular media (for communication with other
cells) causes a change in NPs’ protein corona and aggrega-
tion of NPs outside of cells [44–46]. Albanese and
colleagues showed that between 8 and 24 h of cellular
incubation, the composition of the NP’s protein corona
begins to include more cell-secreted proteins and less
serum proteins from the original media, resulting in
changes in NP aggregation and cellular uptake [44]. This
supports our finding that serum concentration impacted
the magnitude of spectral shift experienced by AuNPs at
early time points of incubation with cells but did not
engender differences in spectral shift after 24 h of incuba-
tion. It is possible that by 24 h of incubation, cell-secreted
proteins and biomolecules have displaced a portion of the
original protein corona and made the protein corona of
the NPs in 10, 25, and 50 % HuS conditions, more
comparable in composition. A second possible reason or
contributing factor for the disappearance of significant
differences in the spectral peak wavelength among the dif-
ferent HuS concentration conditions after 24 h is that the
Fig. 5 Representative cellular TEM images showed the relative number
of PEGylated AuNPs within intracellular vesicles 10 and 24 h after
incubation with Sk-Br-3 cells in various serum concentration conditions.
At 10 h, the cells exposed to PEGylated AuNPs in serum-free conditions
were observed to have the highest number of AuNPs per vesicle,
followed by decreasing numbers of AuNPs per vesicle as the serum
concentration increased. After 24 h, the largest numbers of AuNPs were
found in vesicles when AuNPs were introduced to cells in serum-free
conditions, while a comparable number of AuNPs was found in vesicles
in the serum-containing conditions (10, 25, 50 % HuS)
Chen et al. Nanoscale Research Letters  (2016) 11:303 Page 9 of 12
protein corona evolved to a common composition over
time for NPs incubated in the different serum conditions.
Monopoli et al. showed that such an evolution in the pro-
tein corona over 24 h to a more uniform composition no
longer dependent on the plasma concentration occurred
for sulfonated polystyrene NPs [31]. A third explanation is
that NPs exposed to 10, 25, or 50 % HuS conditions could
undergo different paths of cellular uptake and intracellular
transport due to their distinct protein coronas, explaining
the earlier differences in spectral shift and slight differences
in NPC size seen in TEM images; however, after 24 h, NPs
in high-serum concentration conditions may have had
enough time to “catch up” in cellular internalization to
reach NPC sizes similar to those of NPs incubated with
lower concentrations of serum. Indeed, TEM images of
cells incubated with NPs in 10, 25, and 50 % HuS showed
that similar NPC sizes resulted after 24 h, which can be due
to a combination of these three reasons.
Together, our results suggest that for PEGylated
AuNPs, the serum concentration has a greater effect on
the extent of spectral shift experienced by PEGylated
AuNPs at early times following introduction to cells, but
this effect diminishes with longer incubation time. How-
ever, significant larger spectral shifting is achieved for NPs
in serum-free conditions compared with serum-containing
conditions. As a result, we find that the biological environ-
mental conditions of the applications in which plasmonic
nanoparticles are used—whether a serum-free or serum-
containing environment—will impact the extent of the
change in their optical spectra upon cellular interaction,
likely as a result of the formation of a different protein
corona and engaging different cellular receptors for uptake
and intracellular trafficking.
Conclusions
In this study, we examined how design parameters, such
as PEGylation of NPs and serum concentrations used,
impact the extent that the spectra of plasmonic NPs
change when plasmonic NPs are introduced into a cellu-
lar environment. We found that PEGylation decreases
the magnitude of spectral shift and spectral broadening.
Changes in the spectra of plasmonic AuNPs in cells is
also dependent on the serum concentration in which the
NPs are introduced to the cells. In serum-free condi-
tions, NP spectra shift significantly more, and when NPs
are exposed to cells for short periods of time, spectral
shifts are suppressed in higher serum concentration
environments. Finally, after 24 h of NP-cell exposure, it
appears that the serum concentration of the extracellular
media does not have a significant effect on the extent of
spectral shifting either due to evolution of the protein
corona to a common composition or due to NPs reach-
ing a similar plateau in intracellular agglomeration after
24 h despite initial differences in cellular uptake and
intracellular transport.
These findings suggest that the spectral shifting of plas-
monic NPs in biological environments can be engineered
when designing nanoparticles for biomedical applications.
PEGylation of NPs can decrease spectral shifting and
maintain a narrow spectral width, which may be import-
ant for applications demanding narrow spectral outputs to
minimize spectral overlap of multiplexed NPs. Further-
more, spectral shifts are less pronounced when PEGylated
AuNPs are employed in high-serum environments. While
these trends may differ depending on particle type and cell
type, our findings offer an initial framework for consider-
ing the effect of design parameters on the final spectral
shifting in cells when designing plasmonic nanoparticles
for medical applications. Furthermore, we have demon-
strated the use of darkfield HS imaging for identifying
how NP design parameters and environmental factors
impact the spectral shift plasmonic NPs experience in
cellular environments. Continued work towards elucidat-
ing the cellular interaction, cellular uptake, intracellular
trafficking, and intracellular agglomeration of AuNPs in
parallel with further characterization of how other design
parameters impact plasmonic NP spectral changes in
biological environments will enable the precise design of
plasmonic NPs capable of achieving a targeted optical
response and fate in biomedical systems.
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